Synapse

← Gordon B. Mills

Papers by Gordon B. Mills

Page 12 · newest first

  1. PI3K Pathway Mutations and PTEN Levels in Primary and Metastatic Breast CancerMolecular Cancer Therapeutics · 2011
  2. Benzyl and Naphthalene Methylphosphonic Acid Inhibitors of Autotaxin with Anti‐invasive and Anti‐metastatic ActivityChemMedChem · 2011
  3. Astrocytes Upregulate Survival Genes in Tumor Cells and Induce Protection from ChemotherapyNeoplasia · 2011
  4. A Gene Expression Signature from Human Breast Cancer Cells with Acquired Hormone Independence Identifies MYC as a Mediator of Antiestrogen ResistanceClinical Cancer Research · 2011
  5. Trastuzumab Has Preferential Activity against Breast Cancers Driven by HER2 HomodimersCancer Research · 2011
  6. Incidence and Outcome of BRCA Mutations in Unselected Patients with Triple Receptor-Negative Breast CancerClinical Cancer Research · 2011
  7. Are oncogenes sufficient to cause human cancer?Proceedings of the National Academy of Sciences · 2010
  8. A Technical Assessment of the Utility of Reverse Phase Protein Arrays for the Study of the Functional Proteome in Non-microdissected Human Breast CancersClinical Proteomics · 2010
  9. Rapamycin Regulates Stearoyl CoA Desaturase 1 Expression in Breast CancerMolecular Cancer Therapeutics · 2010
  10. Activation of Murine Double Minute 2 by Akt in Mammary Epithelium Delays Mammary Involution and Accelerates Mammary TumorigenesisCancer Research · 2010
  11. Steroid Receptor Coactivator-3 Expression in Lung Cancer and Its Role in the Regulation of Cancer Cell Survival and ProliferationCancer Research · 2010
  12. PTK6 Regulates IGF-1-Induced Anchorage-Independent SurvivalPLoS ONE · 2010
  13. Identification of Optimal Drug Combinations Targeting Cellular Networks: Integrating Phospho-Proteomics and Computational Network AnalysisCancer Research · 2010
  14. Somatic Mutations in BRCA1 and BRCA2 Could Expand the Number of Patients That Benefit From Poly (ADP Ribose) Polymerase Inhibitors in Ovarian CancerJournal of Clinical Oncology · 2010
  15. Pricing Dynamics in the Australian Airline Market*Economic Record · 2010
  16. Proteomic and transcriptomic profiling reveals a link between the PI3K pathway and lower estrogen-receptor (ER) levels and activity in ER+ breast cancerBreast Cancer Research · 2010
  17. Nicotinic Acetylcholine Receptor Region on Chromosome 15q25 and Lung Cancer Risk Among African Americans: A Case–Control StudyJNCI Journal of the National Cancer Institute · 2010
  18. Personalizing Therapy for Ovarian Cancer: BRCAness and BeyondJournal of Clinical Oncology · 2010
  19. Targeting melanoma growth and viability reveals dualistic functionality of the phosphonothionate analogue of carba cyclic phosphatidic acidMolecular Cancer · 2010
  20. Hyperactivation of phosphatidylinositol-3 kinase promotes escape from hormone dependence in estrogen receptor–positive human breast cancerJournal of Clinical Investigation · 2010
  21. CXCR2 Promotes Ovarian Cancer Growth through Dysregulated Cell Cycle, Diminished Apoptosis, and Enhanced AngiogenesisClinical Cancer Research · 2010
  22. PIK3CA mutations associated with gene signature of low mTORC1 signaling and better outcomes in estrogen receptor–positive breast cancerProceedings of the National Academy of Sciences · 2010
  23. Functional Proteomic Analysis of Advanced Serous Ovarian Cancer Using Reverse Phase Protein Array: TGF-β Pathway Signaling Indicates Response to Primary ChemotherapyClinical Cancer Research · 2010
  24. Aurora Kinase A Promotes Ovarian Tumorigenesis through Dysregulation of the Cell Cycle and Suppression of BRCA2Clinical Cancer Research · 2010
  25. Future of Personalized Medicine in Oncology: A Systems Biology ApproachJournal of Clinical Oncology · 2010
  26. Mammalian Target of Rapamycin Activator RHEB Is Frequently Overexpressed in Human Carcinomas and Is Critical and Sufficient for Skin Epithelial CarcinogenesisCancer Research · 2010
  27. Dose-dependent induction of distinct phenotypic responses to Notch pathway activation in mammary epithelial cellsProceedings of the National Academy of Sciences · 2010
  28. Lysophosphatidic acid production and action: critical new players in breast cancer initiation and progressionBritish Journal of Cancer · 2010
  29. ATM signals to TSC2 in the cytoplasm to regulate mTORC1 in response to ROSProceedings of the National Academy of Sciences · 2010
  30. AMPK‐mediated phosphorylation of murine p27 at T197 promotes binding of 14‐3‐3 proteins and increases p27 stabilityMolecular Carcinogenesis · 2010
  31. Integrative Analysis of Proteomic Signatures, Mutations, and Drug Responsiveness in the NCI 60 Cancer Cell Line SetMolecular Cancer Therapeutics · 2010
  32. Induction of papillary carcinoma in human ovarian surface epithelial cells using combined genetic elements and peritoneal microenvironmentCell Cycle · 2010
  33. Integrated Molecular and Clinical Analysis of AKT Activation in Metastatic MelanomaClinical Cancer Research · 2009
  34. Targeting the Epidermal Growth Factor Receptor in Epithelial Ovarian Cancer: Current Knowledge and Future ChallengesJournal of Oncology · 2009
  35. ATX-LPA receptor axis in inflammation and cancerCell Cycle · 2009
  36. Reciprocal Regulation of c-Src and STAT3 in Non-Small Cell Lung CancerClinical Cancer Research · 2009
  37. Activity of dasatinib against L576P KIT mutant melanoma: Molecular, cellular, and clinical correlatesMolecular Cancer Therapeutics · 2009
  38. The Emerging Role of the RAB25 Small GTPase in CancerTraffic · 2009
  39. 3-Phosphoinositide–Dependent Kinase 1 Potentiates Upstream Lesions on the Phosphatidylinositol 3-Kinase Pathway in Breast CarcinomaCancer Research · 2009
  40. β-Arrestin/Ral Signaling Regulates Lysophosphatidic Acid–Mediated Migration and Invasion of Human Breast Tumor CellsMolecular Cancer Research · 2009
  41. Akt1 and Akt2 Play Distinct Roles in the Initiation and Metastatic Phases of Mammary Tumor ProgressionCancer Research · 2009
  42. Integrative Analysis of Cyclin Protein Levels Identifies Cyclin B1 as a Classifier and Predictor of Outcomes in Breast CancerClinical Cancer Research · 2009
  43. Combined Src and Aromatase Inhibition Impairs Human Breast Cancer Growth In vivo and Bypass Pathways Are Activated in AZD0530-Resistant TumorsClinical Cancer Research · 2009
  44. Lysophosphatidic Acid-Induced Transcriptional Profile Represents Serous Epithelial Ovarian Carcinoma and Worsened PrognosisPLoS ONE · 2009
  45. Loss of Phosphatase and Tensin Homologue Deleted on Chromosome 10 Engages ErbB3 and Insulin-Like Growth Factor-I Receptor Signaling to Promote Antiestrogen Resistance in Breast CancerCancer Research · 2009
  46. Characterization of a Naturally Occurring Breast Cancer Subset Enriched in Epithelial-to-Mesenchymal Transition and Stem Cell CharacteristicsCancer Research · 2009
  47. Dual targeting of AKT and mammalian target of rapamycin: A potential therapeutic approach for malignant peripheral nerve sheath tumorMolecular Cancer Therapeutics · 2009
  48. Phosphorylated 4E-BP1 Is Associated with Poor Survival in MelanomaClinical Cancer Research · 2009
  49. Androgen Receptor Levels and Association with PIK3CA Mutations and Prognosis in Breast CancerClinical Cancer Research · 2009
  50. Cetuximab Attenuates Metastasis and u-PAR Expression in Non–Small Cell Lung Cancer: u-PAR and E-Cadherin are Novel Biomarkers of Cetuximab SensitivityCancer Research · 2009